Treating vitiligo with the goal of repigmentation requires a different approach than simply managing depigmented skin day to day. The products in this guide are chosen specifically for their role in repigmentation protocols: either they have direct clinical evidence for stimulating melanocyte activity, they are used alongside phototherapy to improve outcomes, or they address the specific inflammatory and oxidative mechanisms that block melanocyte recovery. This is a treatment-oriented article; for general management and coverage of vitiligo patches, see our companion guide on the best creams for vitiligo.
| Product | Best For | Key Ingredient | Est. Price |
|---|---|---|---|
| Tacrolimus Ointment 0.1% (Rx) | First-line repigmentation (face/neck) | Tacrolimus | Rx |
| Elidel (Pimecrolimus) Cream 1% (Rx) | Mild-to-moderate, steroid-sparing | Pimecrolimus | Rx |
| Calcipotriol Cream (Rx) | Phototherapy enhancement | Vitamin D analogue | Rx |
| Opzelura (Ruxolitinib) Cream (Rx) | FDA-approved repigmentation | JAK inhibitor | Rx |
| Physiogel Calming Relief AI Cream | OTC barrier support in protocols | Biodermin technology | ~$60-150 |
Tacrolimus Ointment 0.1% (Rx)
Tacrolimus is a calcineurin inhibitor that suppresses the local immune attack on melanocytes without the skin-thinning side effects of long-term corticosteroid use. It is the most widely prescribed non-steroidal topical for vitiligo, particularly on the face, neck, and body folds where steroid use is riskier. The 0.1% concentration is used for adults; 0.03% is used for children. Applied twice daily, it shows repigmentation rates of 40-70% on facial vitiligo within six months in multiple clinical trials, especially when combined with narrowband UVB phototherapy. Available by prescription only.
Elidel (Pimecrolimus) Cream 1% (Rx)
Pimecrolimus works through the same calcineurin-inhibitor mechanism as tacrolimus but has a lighter cream texture that many patients prefer for facial and skin-fold application. Its evidence base for vitiligo is slightly less robust than tacrolimus, but it remains a useful option for patients who find tacrolimus too occlusive or irritating. The cream formulation is particularly well-tolerated on thinner facial skin. It is most effective when used as part of a combination protocol with phototherapy rather than as a monotherapy. Like tacrolimus, it requires a prescription.
Calcipotriol Cream (Rx)
Calcipotriol is a synthetic vitamin D analogue primarily used for psoriasis, but it appears in vitiligo protocols as an adjunct to phototherapy because vitamin D receptors on melanocytes may influence their migration and pigment production. Several small studies have shown improved repigmentation when calcipotriol is applied before or after NB-UVB sessions compared to phototherapy alone. It is less studied in vitiligo than tacrolimus, but dermatologists use it particularly in cases where patients cannot tolerate calcineurin inhibitors or want to avoid all immunosuppressive agents.
Opzelura (Ruxolitinib) Cream (Rx)
Ruxolitinib cream (brand name Opzelura) is the only FDA-approved topical treatment specifically indicated for non-segmental vitiligo repigmentation in adults. It is a JAK1/JAK2 inhibitor that blocks the signaling pathway that drives the autoimmune attack on melanocytes. In the TRuE-V Phase 3 trials, 30% of patients using 1.5% ruxolitinib cream twice daily achieved at least 75% facial repigmentation at 52 weeks, compared to 7% with vehicle. It is significantly more expensive than tacrolimus and requires a prescription, but for motivated patients it represents the most evidence-backed OTC-adjacent repigmentation option currently approved.
Physiogel Calming Relief AI Cream
For patients in active repigmentation protocols, barrier support between sessions matters. Physiogel’s Calming Relief AI Cream uses the brand’s Biodermin technology to deliver a lipid-rich, fragrance-free formula that closely mimics the skin’s natural moisturizing factor. It reduces transepidermal water loss on sensitized patch-adjacent skin without any ingredients that could interfere with topical immunomodulator absorption. It is the OTC option dermatologists most commonly pair with prescription vitiligo regimens to minimize irritation and maintain skin health during prolonged treatment periods.
What to Look For
- Prescription vs. OTC for repigmentation — Meaningful repigmentation generally requires prescription-strength calcineurin inhibitors or JAK inhibitors. OTC products are supportive tools, not primary drivers of repigmentation.
- Evidence base over marketing claims — Avoid products that promise to “restore melanin” without clinical data. Look for ingredients with peer-reviewed repigmentation studies: tacrolimus, pimecrolimus, ruxolitinib, and calcipotriol.
- Phototherapy compatibility — If you are pursuing NB-UVB, confirm with your dermatologist which topicals to apply before vs. after sessions. Some formulations affect light penetration; others enhance the phototherapy response.
- Fragrance-free and minimal excipients — Active patches are more permeable. A clean-formulation carrier cream reduces the risk of sensitization that can complicate treatment response.
Final Thoughts
Vitiligo repigmentation is a medical goal that requires a dermatologist-guided protocol. Prescription options like tacrolimus and Opzelura have the strongest evidence and should be the centerpiece of any treatment plan. OTC products like Physiogel provide essential support between sessions and help the skin tolerate prolonged topical therapy. Commit to a consistent schedule. The biggest predictor of repigmentation success is daily application maintained for at least six months.
Frequently asked questions
What topical treatments have the strongest evidence for vitiligo repigmentation?+
Prescription tacrolimus ointment (0.1%) and topical corticosteroids have the strongest clinical evidence for inducing repigmentation, particularly on the face and neck. Among newer options, ruxolitinib cream (Opzelura) received FDA approval specifically for non-segmental vitiligo repigmentation in adults. OTC options are supportive rather than primary treatments. Any serious repigmentation goal should involve a dermatologist and likely a combination of topical therapy with narrowband UVB phototherapy.
How does narrowband UVB phototherapy combine with topical creams?+
Narrowband UVB (NB-UVB) phototherapy stimulates melanocyte migration and proliferation in and around depigmented patches. Topical treatments are typically applied after (not before) phototherapy sessions to support the skin environment during the repair window. Tacrolimus or a vitamin D analogue like calcipotriol applied post-session can enhance the repigmentation response compared to phototherapy alone, according to multiple dermatology studies. The combination is now considered the standard of care for active vitiligo.
How long does topical vitiligo treatment take to show repigmentation?+
Repigmentation is slow even with effective treatment. In clinical studies with tacrolimus or topical steroids, visible follicular repigmentation (small dots of color appearing within patches) typically begins at 3 to 6 months of consistent use. Full or near-full repigmentation of a patch can take 12 to 24 months, and some areas like hands and feet respond much more slowly than the face. Patience and consistent daily application are essential for any treatment protocol to show results.